In June, South Korean officials approved the creation of the first ever drug, a
COVID vaccination, using a new protein created by humans. The vaccine is
based on a protein "nanoparticle" with a spherical shape that was developed
by scientists over 10 years ago through a labor-intensive trial-and-error process1.
Now, a team led by David Baker, a biochemist at the University of Washington
(UW) in Seattle, reveals in Science2,3 that it can create such molecules in
seconds rather than months because to enormous advancements in artificial
intelligence (AI). Such initiatives are a part of a larger scientific shift as life